Navigation Links
Pharma and Biotech Leaders to Converge in Shanghai

SHANGHAI, Nov. 9 /PRNewswire-Asia/ -- The pharma and biotech sectors are at a pivotal point in their evolution. The companies are facing significant pressure to change with thinning pipelines, skyrocketing R&D costs, calls for lower prices and a greater regulatory burden, these conditions together with the financial crisis have made the work of creating new drugs harder than ever. Big pharmaceutical companies are being forced to globalize their R&D operations, especially to emerging markets.

Under this background, leaders of pharma and biotech companies from around the world will gather in Shanghai on March 4-5, 2010 at Asia Pharma R&D Leaders 2010 for strategies to capitalize on the enormous opportunity the booming Asia Market provides.

This event focuses on the operational, regulatory, and strategic challenges of outsourcing your drug discovery work to Asia.

Hear from distinguished industry experts at Asia Pharma R&D Leaders 2010. Some of this year's highlighted topics include:

    -- Partnering for innovation in Asia, new collaboration opportunities with
       big pharma

       -- Laurent Bertin, Vice President, R&D External Innovation, Sanofi-
       -- Hans-Jochiam Bohm, Head of Global Chemistry, Hoffman La-Roche
       -- Daniel Grant, Head of Strategic Alliances, Pfizer Australia
       -- Pierre Desmons, Director, Head of Development Partnerships,
          GlaxoSmithKline Biologicals

    -- Regulatory updates in China and how FDA is making sure the quality of
       outsourced work

       -- Christopher Hickey, Country Director (China), U.S. Food and Drug

    -- Successful stories of R&D operation management in Asia and Do's &
       Don'ts in outsourcing

       -- Steve Yang, Head of Research Asia Global R&D, Pfizer
       -- Lily Lee, Senior Vice President and Head of Pharmaceutical R&D Asia,
          Johnson and Johnson
       -- Li Chen, Chief Scientific Officer Roche R&D China
       -- Tony Zhang, Managing Director and Site Head of China, Eli Lilly
          Global R&D
       -- Samantha Du, CEO, Hutchison MediPharma
       -- Richard Wang, Director, Strategic Alliance and Collaboration for
          Asia, AstraZeneca
       -- Yoshiki Nishikawa, Director of Kobe Pharma Research Institute Nippon,
          Boehringer Ingelheim

Plus, the event sets up an effective platform for you to meet face to face with a variety of Asia's local CROs and leading clinical practitioners to discuss the specifics of your outsourcing requirements.

An international audience consisting of senior-level pharma and biotech executives from the R&D, clinical development, business development, global market access, licensing, and regulatory affairs functions will be in attendance. For the full program and list of companies scheduled to attend, please visit the event website at .

For more information on registration and sponsoring/exhibiting, please contact:

Daniel Chen

Tel: +86-21-3251-6110


SOURCE Global Leaders Institute

SOURCE Global Leaders Institute
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Helix BioPharma to Present at Merriman Curhan Fords Investor Summit 2009 on November 10th
2. Leaders in Biopharma and Molecular Diagnostics to Discuss Key Issues and Opportunities in Forming Partnerships at 2010 Personalized Medicine Partnerships Conference
3. DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix
4. Onyx Pharmaceuticals to Present at the Credit Suisse 18th Annual Healthcare Conference
5. Optimer Pharmaceuticals Reports Third Quarter 2009 Financial Results
6. ISTA Pharmaceuticals Reports Third Quarter 2009 Financial Results
7. Poniard Pharmaceuticals Reports Third Quarter 2009 Financial Results and Provides a Corporate Update
8. OncoGenex Pharmaceuticals to Release Third Quarter 2009 Financial Results
9. Laureate Pharma Welcomes Three New Members to Business Development Team
10. Pharmasset to Webcast an Investor Event from the AASLD Meeting
11. ViroPharma to Present at Three November Healthcare Conferences
Post Your Comments:
(Date:6/27/2016)... 27, 2016  Global demand for enzymes is ... 2020 to $7.2 billion.  This market includes enzymes ... products, biofuel production, animal feed, and other markets) ... biocatalysts). Food and beverages will remain the largest ... consumption of products containing enzymes in developing regions.  ...
(Date:6/27/2016)... San Diego, CA (PRWEB) , ... June 27, 2016 , ... ... mClinical solutions for clinical trials, announced today the Clinical Reach Virtual Patient ... and their care circle with the physician and clinical trial team. , Using the ...
(Date:6/27/2016)... Ginkgo Bioworks , a leading organism design company ... as one of the World Economic Forum,s Technology ... companies. Ginkgo Bioworks is engineering biology to manufacture ... the nutrition, health and consumer goods sectors. The ... Fortune 500 companies to design microbes for their ...
(Date:6/24/2016)... ... ... Researchers at the Universita Politecnica delle Marche in Ancona combed medical journal articles ... findings are the subject of a new article on the Surviving Mesothelioma website. ... blood, lung fluid or tissue of mesothelioma patients that can help point doctors to ...
Breaking Biology Technology:
(Date:6/22/2016)... -- On Monday, the Department of Homeland Security (DHS) ... for the Biometric Exit Program. The Request for Information ... explains that CBP intends to add biometrics to confirm ... States , in order to deter visa overstays, ... Logo - ...
(Date:6/15/2016)... 15, 2016 Transparency Market ... Recognition Market by Application Market - Global Industry Analysis Size ... to the report, the  global gesture recognition market ... and is estimated to grow at a CAGR ... 2024.  Increasing application of gesture recognition ...
(Date:6/3/2016)... 3, 2016 Das ... Nepal hat ein 44 ... geprägter Kennzeichen, einschließlich Personalisierung, Registrierung und IT-Infrastruktur, ... Produktion und Implementierung von Identitätsmanagementlösungen. Zahlreiche renommierte ... Januar teilgenommen, aber Decatur wurde als konformste ...
Breaking Biology News(10 mins):